IBDEI0GT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7503,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,7503,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,7504,0)
 ;;=E10.40^^52^503^5
 ;;^UTILITY(U,$J,358.3,7504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7504,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,7504,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,7504,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,7505,0)
 ;;=E10.22^^52^503^2
 ;;^UTILITY(U,$J,358.3,7505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7505,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,7505,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,7505,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,7506,0)
 ;;=E10.9^^52^503^7
 ;;^UTILITY(U,$J,358.3,7506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7506,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,7506,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,7506,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,7507,0)
 ;;=E11.22^^52^503^8
 ;;^UTILITY(U,$J,358.3,7507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7507,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,7507,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,7507,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,7508,0)
 ;;=E11.9^^52^503^12
 ;;^UTILITY(U,$J,358.3,7508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7508,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,7508,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,7508,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,7509,0)
 ;;=E13.22^^52^503^1
 ;;^UTILITY(U,$J,358.3,7509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7509,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,7509,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,7509,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,7510,0)
 ;;=E83.30^^52^504^25
 ;;^UTILITY(U,$J,358.3,7510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7510,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,7510,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,7510,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,7511,0)
 ;;=E83.31^^52^504^9
 ;;^UTILITY(U,$J,358.3,7511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7511,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,7511,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,7511,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,7512,0)
 ;;=E83.51^^52^504^18
 ;;^UTILITY(U,$J,358.3,7512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7512,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,7512,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,7512,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,7513,0)
 ;;=E83.52^^52^504^12
 ;;^UTILITY(U,$J,358.3,7513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7513,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,7513,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,7513,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,7514,0)
 ;;=E87.0^^52^504^15
 ;;^UTILITY(U,$J,358.3,7514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7514,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
 ;;^UTILITY(U,$J,358.3,7514,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,7514,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,7515,0)
 ;;=E87.1^^52^504^17
 ;;^UTILITY(U,$J,358.3,7515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7515,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,7515,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,7515,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,7516,0)
 ;;=E87.2^^52^504^1
 ;;^UTILITY(U,$J,358.3,7516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7516,1,3,0)
 ;;=3^Acidosis
 ;;^UTILITY(U,$J,358.3,7516,1,4,0)
 ;;=4^E87.2
 ;;^UTILITY(U,$J,358.3,7516,2)
 ;;=^5003020
 ;;^UTILITY(U,$J,358.3,7517,0)
 ;;=E87.3^^52^504^3
 ;;^UTILITY(U,$J,358.3,7517,1,0)
 ;;=^358.31IA^4^2
